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ABSTRACT ForDNAviruses,geneticrecombination,addition,anddeletionrepresentimportantevolutionarymechanisms.Since
thesegeneticalterationscanleadtonew,possiblyseverepathogens,weappliedasystemsbiologyapproachtostudythepathoge-
nicityofanovelhumanadenoviruswithanaturallyoccurringdeletionofthecanonicalpentonbaseArg-Gly-Asp(RGD)loop,
thoughttobecriticaltocellularentrybyadenoviruses.BioinformaticanalysisrevealedanewhighlyrecombinantspeciesDhu-
man adenovirus (HAdV-D60). A synthesis of in silico and laboratory approaches revealed a potential ocular tropism for the new
virus. In vivo, inﬂammation induced by the virus was dramatically greater than that by adenovirus type 37, a major eye patho-
gen,possiblyduetoanovelalternateligand,Tyr-Gly-Asp(YGD),onthepentonbaseprotein.Thecombinationofbioinformat-
icsandlaboratorysimulationmayhaveimportantapplicationsinthepredictionoftissuetropismfornewlydiscoveredand
emergingviruses.
IMPORTANCE Theongoingdancebetweenavirusanditshostdistinctlyshapeshowthevirusevolves.Whilehumanadenoviruses
typicallycausemildinfections,recentreportshavedescribednewlycharacterizedadenovirusesthatcausesevere,sometimes
fatalhumaninfections.Here,wereportasystemsbiologyapproachtoshowhowevolutionhasaffectedthediseasepotentialofa
recentlyidentiﬁednovelhumanadenovirus.Acomprehensiveunderstandingofviralevolutionandpathogenicityisessentialto
ourcapacitytoforetellthepotentialimpactonhumandiseasefornewandemergingviruses.
Received 12 December 2012 Accepted 12 March 2013 Published 9 April 2013
Citation Robinson CM, Zhou X, Rajaiya J, Yousuf MA, Singh G, DeSerres JJ, Walsh MP, Wong S, Seto D, Dyer DW, Chodosh J, Jones MS. 2013. Predicting the next eye pathogen:
analysis of a novel adenovirus. mBio 4(2):e00595-12. doi:10.1128/mBio.00595-12.
Invited Editor Mathew Weitzmann, University of Pennsylvania Editor Herbert Virgin, Washington University School of Medicine
Copyright © 2013 Robinson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported
license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to James Chodosh, james_chodosh@meei.harvard.edu, or Morris S.Jones, mjones30@gmu.edu.
C.M.R. and X.Z. contributed equally to this work.
I
nfection entails complex and functionally integrated relation-
ships between pathogen and host (1, 2). The synthesis of
genomic, bioinformatic, cellular, and molecular methodologies
permits a systems biology approach to predict the emergence of
new and severe infectious agents. Human adenoviruses (HAdV)
are ubiquitous, cause infections in the respiratory, gastrointesti-
nal, genitourinary, and ocular mucosas, can be opportunistic in
the immune-compromised host, and have been associated with
obesity (3–8). Adenoviruses also are common choices for gene
therapy vectors (9, 10). Thus, while adenoviruses continue to
cause signiﬁcant morbidity and mortality in the human popula-
tion, their existence also provides a potential beneﬁt for the treat-
ment of patients with an even broader range of ailments.
Since the ﬁrst adenovirus was characterized in 1953 (11, 12),
over 60 human adenoviruses have been recognized as unique
types. Analysis of whole-genome sequence data for existing and
newHAdVsconﬁrmedacriticalroleforhomologousrecombina-
tion in adenovirus evolution, leading to new and sometimes seri-
ous human infections (13–18). The emergence of new HAdV
types,withseveralassociatedwithsevereeyeinfection(13,16,18),
promptedustoapplyasystemsbiologyapproachtotrytopredict
the ocular tropism of a previously uncharacterized and highly
novel HAdV, isolated by nasopharyngeal swab from a 4-month-
oldboywithseverebronchiolitis.Acombinedgenomic,bioinfor-
matic,andbiologicalanalysisidentiﬁedauniquedeletioninakey
protein of the viral capsid and further suggested the potential of
this virus to cause signiﬁcant ocular infection. These results point
towardapossibleapproachforpredictingpathogenicityfornewly
identiﬁed and recently emergent human pathogens.
RESULTS
The HAdV-D60 penton base gene has a unique deletion of the
hypervariable RGD loop. Viral cultures were obtained by naso-
pharyngeal swab from a male child with bronchiolitis. Initial test-
ing suggested a mixed infection with adenovirus and human
metapneumovirus. Limited genomic sequencing of the adenovi-
rus suggested a unique adenovirus type. Subsequent whole-
genome sequencing, phylogenetic analysis, and viral neutraliza-
tion assays for the adenovirus in the specimen revealed the novel
adenovirus to be a recombinant of several human adenoviruses,
with sequence contributions from HAdV-D20 (hexon gene) and
HAdV-D37 (penton base gene) but with a unique ﬁber gene
(Fig.1A;seealsoFig.S1toS3inthesupplementalmaterial).Thus,
this new human adenovirus species D type (HAdV-D) was desig-
nated HAdV-D60, based on current typing criteria (19). Unex-
pectedly, sequence analysis revealed deletion of the Arg-Gly-Asp
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base protein (Fig. 1B and D), which is normally highly conserved
and thought to mediate an interaction with host cell integrins
critical to viral entry, e.g., v3 (20). HAdV-D60 is the ﬁrst virus
withinthespeciesHAdV-DthatwasfoundtolackanRGDloopor
similar motif. Despite the deleted RGD loop, SimPlot analysis of
the entire penton base gene conﬁrmed extensive identity between
HAdV-D60andHAdV-D37(Fig.1C;Fig.S1andS3A),thelattera
major cause of epidemic keratoconjunctivitis.
HAdV-D60 infects the ocular surface epithelium. We re-
cently demonstrated that entry of a human adenovirus into hu-
man corneal epithelial cells in vitro can differentiate a corneal
pathogen (21). The absence of the RGD loop in the penton base
protein in HAdV-D60, with otherwise high similarity to HAdV-
D37throughouttherestofthegene,ledustotestwhetherHAdV-
D60 would infect ocular surface epithelial cells. By confocal mi-
croscopy with Cy3-labeled virus, HAdV-D60 enters both corneal
(THE) and conjunctival (Chang) epithelial cells by 1 h postinfec-
tion.Thiswascomparedtothe30-minuteentryseenwithHAdV-
D37(Fig.2A;seealsoFig.S4andS5inthesupplementalmaterial).
Viralreplication(Fig.2B)andE1Atranscription(Fig. 2C;Fig.S6)
forHAdV-D60alsooccurredbutweredelayedcomparedtothose
for HAdV-D37. Together, these data demonstrate that HAdV-
D60 infects and replicates in ocular surface epithelial cells, albeit
more slowly than HAdV-D37.
HAdV-D60infectsthecorneainvivoandishyperinﬂamma-
tory. Since in vitro infection of ocular surface epithelial cells was
consistent with corneal tropism, we examined the capacity of
HAdV-D60toinducecornealinﬂammationinvivobytestingvar-
ioustitersofthevirusinanadenoviruskeratitismousemodel(22,
23). Surprisingly, HAdV-D60 induced threshold clinical inﬂam-
mation at an infectious dose considerably (~100-fold) lower than
thatforHAdV-D37(Fig.2D;seealsoFig.S7Ainthesupplemental
material). By ﬂow cytometry, roughly 4-fold more inﬁltrating
CD45cellsinﬁltratedtheHAdV-D60-infectedcorneathaninﬁl-
tratedcorneaswithsimilartitersofHAdV-D37(Fig. 2E).Consis-
tent with increased inﬁltration by leukocytes, cytokine levels of
interleukin 6 (IL-6), CXCL1, CXCL10, alpha interferon (IFN-),
and IFN- in the corneas of HAdV-D60-injected mice were sig-
niﬁcantlyelevatedcomparedtothoseinmicewithcontrolHAdV-
FIG1 GenomicanalysisofHAdV-D60.(A)Whole-genomephylogeneticanalysisofHAdV-D60.(B)Multisequencealignmentofthepentonbaseproteinfrom
a representative type from each HAdV species. The highly conserved RGD sequence is bolded and boxed in red. (C) SimPlot analysis of the HAdV-D60 penton
base gene queried against all completely sequenced HAdV-D penton base genes. The location, in relation to the nucleotide sequence, of the two major
hypervariable loop (HVL1 and RGD) domains of the protein are presented above the graph. HAdV-D37 sequence similarity is presented in red. (D) Predicted
protein model of the HAdV-D60 penton base based on homology modeling of the crystal structure of HAdV-C2. The absence of the RGD loop in HAdV-D60
is shown in red (arrow). The RGD loop for HAdV-C2 was not resolved in crystal structure and was modeled and added (arrow and in red).
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D60 capably induces keratitis in the mouse.
HAdV-D60 contains a novel potential integrin binding mo-
tif. We previously showed that administration of an RGD 15-mer
identical to the RGD loop in HAdV-D37, when coinjected with
HAdV-D37,reducedresultantinﬂammationcomparedtoaKGE-
containingcontrol15-merotherwiseidenticaltotheRGDpeptide
(23).BecauseHAdV-D60lacksthepentonbaseproteinRGDmo-
tif thought essential for viral internalization via binding to and
aggregation of host cellular integrins, we predicted that a similar
experiment performed with HAdV-D60 would show no suppres-
sionofcornealinﬂammationbyeithertheRGD15-meroritsKGE
control.Surprisingly,administrationoftheRGD15-meridentical
to the RGD loop in HAdV-D37, when coinjected with HAdV-
D60, reduced resultant inﬂammation compared to the KGE-
containing control (Fig. 3A), suggesting that integrin binding re-
mained an important element in the pathogenesis of infection or,
less likely, suggesting a direct effect of the RGD ligand on the
immune response (24). Protein modeling of the HAdV-D60 pen-
ton base illustrated the RGD loop deletion, but also identiﬁed a
Tyr-Gly-Asp (YGD) motif (Fig. 3B), on the outer upper region of
the modeled penton base protein. This motif was found to be
conserved in all known HAdV-D penton base genes, suggesting
novel and redundant strategies for penton-mediated integrin
bindingandaggregation(25).Notably,aYGD15-meridenticalto
the amino acid sequence surrounding YGD in the HAdV-D60
pentonbaseproteinpreventedbindingofHAdV-D60tocultured
humancornealﬁbroblasts(Fig.3C).Previousworkdemonstrated
akeyrolefordownstreamexpressionofCXCL8inhumanadeno-
virus keratitis (26). Treatment of human corneal ﬁbroblasts with
the YGD 15-mer also reduced CXCL8 expression in HAdV-D60
infection(Fig.3D)andabrogatedclinicalandhistologicalkeratitis
in the HAdV-D60-infected mouse cornea compared to those in
the KGE control (Fig. 3E), suggesting a possible role for the YGD
motif on the penton base. No other potential integrin ligand was
found on the HAdV-D60 penton base protein.
DISCUSSION
Here, we report the identiﬁcation of a novel human adenovirus
and possible bronchial pathogen, HAdV-D60, which is partially
recombinant with HAdV-D37, a known eye pathogen, and we
describeanapproachtotestitspotentialtocausesevereeyeinfec-
tions. Whole-genome sequencing revealed a recombinant ge-
nomewitharecombinedandRGDloop-deletedHAdV-D37pen-
FIG 2 Entry, replication, and inﬂammation of HAdV-D60. (A) Entry of Cy3-labeled HAdV-D60 in human lung (A549), conjunctival (Chang), and corneal
(THE)epithelialcells.(B)GrowthofHAdV-D37(black)andHAdV-D60(red)inA549(squares),Chang(circles),andTHE(triangle)cellsinvitro.(C)Viralgene
expressionofHAdV-D37andHAdV-D60E1A13SinChangcells.(D)InvivoinfectionofHAdV-D37andHAdV-D60atvarioustiters.Clinicalpicturesrepresent
inﬂammation at 4 days postinfection. (E) Flow cytometry analysis of CD45 events following in vivo infection of HAdV-D37 (black) and HAdV-D60 (red). (F)
ELISAanalysisofthecytokinesIL-6,CXCL1,andCXCL1016hafterinvivoinfectionsofHAdV-D37(black)andHAdV-D60(red).Errorbarsrepresentstandard
deviations. n  3 for all experiments. *, P  0.05 (two-way ANOVA).
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thought to enable viral entry via host cellular integrins for all hu-
man adenoviruses (20, 27). HAdV-D60 represents the ﬁrst re-
ported HAdV within species D lacking the speciﬁc RGD motif,
andthisistheﬁrstreportofanyHAdVmissingtheRGDloopinits
entirety. Notably among previously known HAdVs, HAdV-F40
andHAdV-F41expressanexternalpentonbaseloopwithamod-
iﬁed integrin binding motif (28, 29); the loop on HAdV-F40 pen-
tonbaseproteinexpressesRGAD,whileHAdV-F41’spentonbase
loop has IGDD.
ThecapacityofHAdV-D60,withapentonbaseproteinsimilar
to that of HAdV-D37, to infect the ocular surface epithelium and
induce keratitis despite the absence of an RGD loop suggests that
other components of the penton base protein may play a role in
tissue tropism. It is known that the ﬁber protein (see Fig. S3B in
the supplemental material), in particular, the ﬁber knob, is an
important determinant of tropism for the ocular surface epithe-
lium. A single amino acid change in the knob domain of the ﬁber
protein was implicated in conjunctival tropism (30). The ﬁber of
HAdV-D60 was most similar to that of HAdV-D20, a virus not
known to infect the ocular surface. Therefore, we predict effects
on viral tropism also by other viral components beyond the ﬁber
and penton base. Interestingly, in the absence of the RGD-
containing penton base loop, HAdV-D60 infection of conjuncti-
val and corneal cells in vitro appeared to be slowed relative to that
with HAdV-D37 and viral gene expression was considerably de-
layed. Thus, the RGD loop appears to be important but dispens-
ableforviralentry,possiblyduetoasurrogateYGDintegrinbind-
ing motif on the virus. It is intriguing that HAdV-F40 and -F41,
whicharerelativelyfastidiousentericviruses(28,31),alsolackthe
pentonbaseproteinRGDmotifandexpressthepentonbaseYGD
motif (28, 29). It is unknown at present whether the YGD on the
adenovirus penton base protein is exposed sufﬁciently to interact
withcellularintegrinsduringvirusattachmentandentry.Crystal-
lization of the HAdV-D60 penton base protein is in progress and
may help resolve this question. Alternatively, free or altered pen-
tonbasecapsomerduetopartialvirusuncoatingatthecellsurface
may aggregate cellular integrins and assist in viral entry after ﬁber
knob binding (32, 33). Future work is needed to identify whether
YGD represents a novel and redundant motif for adenovirus in-
ternalization. If inﬂammation is initiated by virus binding to its
cellular receptor(s), then perhaps delayed internalization by
FIG3 HAdV-D60interactionwithhostcellularintegrins.(A)InvivoinfectionofHAdV-D60inthepresenceofeithera15merpeptidecontainingArg-Gly-Asp
(RGD) motif or a control 15mer peptide containing Lys-Gly-Glu (KGE). Clinical pictures represent inﬂammation at 4 days postinfection. (B) Homology
modeling of the pentameric structure of the HAdV-D60 penton base. The location of a Tyr-Gly-Asp (YGD) motif on the putative structure is identiﬁed in red.
(C) In vitro entry of HAdV-D60 into human corneal ﬁbroblasts in the presence of a 15mer peptide containing YGD or KGE. (D) CXCL8 expression in human
corneal ﬁbroblasts at 4 h after infection in vitro with HAdV-D60 in the presence of peptide containing either RGD, YGD, or KGE. (E) In vivo infection of
HAdV-D60inthepresenceofpeptidecontainingeitherYGDorKGE.Clinicalpictures(top)andhematoxylinandeosin(H&E)-stainedtissuesections(bottom)
showinﬂammationat4dayspostinfection.Errorbarsrepresentstandarddeviations.n3forallexperiments.*,P0.05(ANOVAwithpreplannedcontrasts).
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ﬂammatory capacity in the cornea in vivo.
Our data suggest that HAdV-D60 may cause ocular infection,
butoursynthesiscanonlypredict,notforetellwithcertainty.Fur-
ther, it is unclear to what degree HAdV-D60 is currently or might
in the future become prevalent in the community. At present, the
population distribution of HAdV-D60 is unknown, but another
virus identical to HAdV-D60 with the exception of a recombined
E3 transcription unit was recently isolated from the gastrointesti-
nal tract of an HIV-infected patient in England (GenBank acces-
sion number JN162672) (34), suggesting that genome variants of
HAdV-D60 may be in circulation outside Canada. Whole-
genome sequencing recently identiﬁed 10 new or previously un-
identiﬁed HAdV types, and surprisingly, three of these were iso-
lated from patients with epidemic keratoconjunctivitis (13, 16,
18). Until or unless HAdV-D60 is identiﬁed in an outbreak of
ocular infection, the true ocular pathogenicity of HAdV-D60 will
remain unknown. The synthesis of in silico, in vitro, and in vivo
experimental approaches, here applied to a novel virus in a hy-
pothesized ocular infection, represents one potential means to
predicttropismandpathogenicityforneworemerginginfectious
agents before they cause serious outbreaks of disease.
MATERIALS AND METHODS
Virus, cells, and animals. HAdV-D60 (GenBank accession number
HQ007053) was cultured from a 4-month-old male infant with bronchi-
olitis in Edmonton, Canada. Respiratory virus testing was performed at
the Provincial Laboratory for Public Health, Calgary, Canada. Nasopha-
ryngeal swab test results for inﬂuenza A virus, inﬂuenza B virus, parain-
ﬂuenza (types 1, 2, 3, and 4), and respiratory syncytial virus A and B were
negative,buttestingresultsforadenovirusandhumanmetapneumovirus
were positive. Blood and urine cultures were negative. HAdV-D60 was
cultureddirectlyfromanasopharyngealswabusingA549cellcultureand
identiﬁed as a potentially novel virus on the basis of limited Sanger se-
quencing of the virus capsid hexon gene. Subsequent whole-genome se-
quencing led to typing of the virus as HAdV-D60, the next available type
number in GenBank, on the basis of its unique genome and phylogenetic
analysis, as approved by the Human Adenovirus Working Group (http:
//hadvwg.gmu.edu/) (19), a collaboration between the adenovirology
community and the National Center for Biotechnology Information
(NCBI, Bethesda, MD). HAdV-D37 (GenBank accession number
DQ900900) was obtained from the American Type Culture Collection
(ATCC, Manassas, VA). For use in these studies, HAdV-D37 and HAdV-
D60 stocks were grown in A549 cells and puriﬁed by a cesium chloride
gradient.
Human lung carcinoma cell line A549 (CCL-185), a human alveolar
epithelial cell line that was previously shown to support HAdV virion
production (35), was obtained from ATCC. Telomerase-immortalized
human corneal epithelial (THE) cells were the kind gift of Jerry Shay
(University of Texas—Southwestern Medical Center) and were cultured
in deﬁned keratinocyte serum-free medium with supplements (Gibco,
Grand Island, NY). Human conjunctival epithelial (Chang) cells were
obtainedfromtheATCC.Primaryhumancornealﬁbroblasts(HCF)were
isolated from human donor corneas as previously described (26). Cells
weremaintainedinDulbecco’smodiﬁedEagle’smediumcontaining10%
heat-inactivated fetal bovine serum. Eight- to 12-week-old wild-type fe-
maleC57BL/6JmicewerepurchasedfromJacksonLaboratories(BarHar-
bor, ME).
The research described in this study conformed to the tenets of the
Declaration of Helsinki. The virus studied was cultured from a human
patient as part of routine clinical care, deemed necessary by the clinical
provider. The virus isolate would otherwise have been discarded and was
deidentiﬁedforanalysisandwasthereforedeterminedtobeexemptfrom
review by the Human Studies Committee at the Massachusetts Eye and
EarInﬁrmary,aHarvardMedicalSchoolafﬁliate.Allanimalsusedinthis
study were treated humanely and in full agreement with the Association
forResearchinVisionandOphthalmologyresolutiononusageandtreat-
ment of animals in research. Approval for the use of animals in this study
wasobtainedfromtheMassachusettsEyeandEarInﬁrmaryAnimalCare
Committee.
Genome sequencing, annotation, and analysis. Puriﬁed HAdV-D60
DNA was sequenced on a Roche 454 DNA sequencer (Branford, CT) by
Euroﬁns MWG Operon (Huntsville, AL). Gaps, ambiguous sequences,
and the inverted terminal repeats were sequenced using an ABI 3130xl
(Applied Biosystems, Carlsbad, CA) via PCR ampliﬁcation. Quality con-
trol included sequence annotation and comparison with HAdV genome
landmarks.DatawereassembledusingCLCGenomicssoftware(CLCbio;
Cambridge, MA), with anN50 average of 5,260. Minimal sequence cover-
ages were 8-fold (Sanger chemistry) and 17- to 20-fold (Next Gen), with
the Next Gen data noted by Operon at an accuracy of greater than 99%
(Q20 or better).
The software programs mVISTA Limited Area Global Alignment of
Nucleotides (LAGAN; http://genome.lbl.gov/vista/lagan/submit.shtml)
and Molecular Evolutionary Genetics Analysis (MEGA) version 4.0.2
(http://www.megasoftware.net) were used for global pairwise sequence
alignment and phylogenetic analysis as previously described (14, 15, 18,
36–41). For phylogenetic trees, branches with bootstrap values below 70
(indicativeoflowconﬁdence)werecollapsed.DNAsequencerecombina-
tion analysis was performed with SimPlot 3.5.1 software (http://sray.med
.som.jhmi.edu/SCRoftware/simplot/), including the options of Bootscan
and SimPlot analysis, to identify possible recombination sites (42). De-
fault settings were used, and HAdV-D60 was used as the reference se-
quence for analysis.
Proteinanalysisandmodeling.Multisequenceaminoacidalignment
was performed using CLC sequence viewer 6 (http://www.clcbio.com
/index.php?id28). A model of the HAdV-D60 penton base was con-
structed using Swiss-Model (http://swissmodel.expasy.org/) for homol-
ogy modeling (43, 44). The crystal structure of HAdV-C2 (45) (Protein
Data Bank [PDB] no. 1X9T) was used as a template for the model. The
identitybetweentheHAdV-C2pentonbaseandtheHAdV-D60pentonbase
was 77%. The model generated by Swiss-Model was evaluated by PRO-
CHECK (http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/) and a
Ramachandran plot, which identiﬁed 82.7% of residues in most-favored re-
gions and 14.9% in additional allowed regions. To model the missing RGD
loop from the crystal structure of the HAdV-C2 penton base, the RGD loop
consisting of 78 amino acids was modeled using the Robetta Server (http:
//robetta.bakerlab.org/). Robetta provides both ab initio and comparative
models of protein domains and uses the Rosetta fragment insertion method.
FivePDBﬁlesweregeneratedforthestructureofthehypervariableRGDloop
of HAdV-C2. One model was chosen and ﬁt by DeepView software (http:
//spdbv.vital-it.ch/)onthecrystalstructureofHAdV-C2togetthefullpenton
protein. UCSF Chimera software (http://www.cgl.ucsf.edu/chimera) (46)
was used for visualization and analysis.
Experimental infections. Cells grown to 80 to 90% conﬂuence were
infectedintriplicatewithvirusatamultiplicityofinfection(MOI)of5or
mock infected with virus-free dialysis buffer, and virus-infected cells
and/or supernatants were harvested at indicated time points and assayed,
as described below. For some infections, HAdV-37 and HAdV-D60 were
conjugated with Cy3 dye (GE Healthcare, Piscataway, NJ) according to
the methods of Leopold et al. (47). One milligram of Cy3 dye was recon-
stituted in 1 ml of 0.1 M sodium bicarbonate (pH 9.3). Labeling was
performed by conjugating Cy3 dye to virus at a concentration approxi-
mately equal to 1012 AdV particles/ml, where reconstituted Cy3 dye was
20%oftheﬁnalsolution.Themixturewasallowedtoincubatefor30min
inthedarkwithgentlemixingevery10min,followedbyovernightdialysis
to remove the excess Cy3 dye.
Mice were anesthetized by intramuscular injection of ketamine
(85 mg/kg of body weight) and xylazine (14 mg/kg). Anesthetic drops
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topically to each eye before injections. One microliter of virus (103 to 105
tissue culture infective dose [TCID]) or virus-free dialysis buffer was in-
jected into the central corneal stroma with a glass micropipette needle
ﬁtted with a gas-powered microinjection system (MDI, South Plainﬁeld,
NJ) under an ophthalmic surgical microscope (Carl Zeiss Meditec, Inc.,
Thornwood, NY). At indicated time points, mouse corneas were photo-
graphedandmicewereeuthanizedusingCO2inhalationpriortoremoval
of corneas for histology and other studies.
Viralgrowthcurve.A549,Chang,andTHEcellsweregrownin6-well
plates and infected in triplicate with virus at a MOI of 1. Following a 1-h
incubation period to allow viral absorption, cells were washed twice with
phosphate-bufferedsaline(PBS)toremoveunboundvirusandfreshme-
diumwasadded.Cellsandsupernatantswerecollectedtogetherat1,2,3,
and 7 days postinfection and freeze thawed. Supernatants were collected
after centrifugation (5,000 rpm for 5 min), and titers of samples were
determined on A549 cells.
RT-PCRanalysisofE1A13Sexpression.A549,Chang,andTHEcells
were infected with virus at an MOI of 5. Following a 1-h incubation, cells
werewashedtwicewithPBSandfreshmediumwasadded.TotalRNAwas
isolated with Trizol (Invitrogen, Eugene, OR) according to the manufac-
turer’s instructions at indicated time points. To eliminate any contami-
nation by genomic DNA, RNA samples were treated with
Turbo DNase (Ambion, Austin, TX). RNA samples were analyzed on a
Bio-Rad SmartSpec Plus (Bio-Rad, Hercules, CA) spectrophotometer for
concentrationandpurity.EliminationofDNAwasconﬁrmedbyabsence
of visible bands for DNase-treated RNA used as a template (no reverse
transcriptase [*Cm5: Zehava Robbins: Is “RT” correctly deﬁned as “re-
verse transcriptase,” implying that “RT-PCR” is “reverse transcriptase
PCR”? Or should it be “reverse transcription-PCR”?RT] control). RT-
PCR was preformed on the samples as described previously (48).
Confocal microscopy. For confocal microscopy, A549, THE, and
Chang cells were grown on slide chambers (Nunc, Rochester, NY) and
infected with Cy3-labeled virus for 30 min and 1 h. HCF were pretreated
with RGD, YGD, or their control 15-mers (see below) for 30 min prior to
infection with Cy3-labeled virus. Cells were then partially ﬁxed in 0.05%
paraformaldehyde for 10 min, washed in PBS containing 2% fetal bovine
serum (FBS), and permeabilized in solution containing 0.1% Triton
X-100 in 2% bovine serum albumin (BSA) for 10 min. After 30 min
blocking in 2% BSA-PBS, the cells were incubated in 5 g/ml of 488-
conjugated phalloidin (Invitrogen, Eugene, OR) for1ha troom temper-
ature.Cellswerethenwashed,ﬁxedin2%paraformaldehydefor10minat
25°C, and coverslipped using mounting medium containing DAPI (4,6-
diamidino-2-phenylindole; Vectashield; Vector Laboratories, Burlin-
game, CA). Samples were scanned with a confocal laser scanning micro-
scope (TCS SP5; Leica, Heidelberg, Germany).
Inhibition of infection by adenoviral penton base peptides. Syn-
thetic 15-mer peptides were obtained from GenScript Corporation (Pis-
cataway,NJ).ThesequenceoftheHAdV-D37wild-typepentonbasepep-
tide including the RGD loop was DAVPRGDNYASAAEA, and the
negative-control peptide, with KGE in place of RGD, was DAVPKG-
ENYASAAEA. The sequence of the HAdV-D60 wild-type penton base
peptide including YGD was LSYTYGDPEKGVQSW, and the negative-
control peptide with KGE instead of YGD was LSYTKGEPEKGVQSW.
The peptides were dissolved in water and diluted in phosphate-buffered
saline(PBS),usedat1mMtopretreathumancelllinesfor30minpriorto
in vitro infection. In experimental mouse infections, 0.5 l of peptide
(2mM)wasmixedwith0.5lvirus(2105TCID)orvirus-freedialysis
bufferandinjectedintothecornealstromaofwild-typemiceasdescribed
above. Mouse corneas were photographed at 4 days postinfection and
removed for histology. Both the RGD- and YGD-containing 15-mers—
but not their KGD-containing controls—had reduced adhesion when
mixed with epithelial cells and ﬁbroblasts on plastic tissue culture plates;
adhesion was also restricted by EDTA.
ELISA.HumancellswereinfectedintriplicatewitheitherHAdV-D60,
HAdV-D37, or virus-free dialysis buffer and supernatants harvested for
an enzyme-linked immunosorbent assay (ELISA) at 4 h postinfection for
protein detection. Mouse corneas were removed at 16 h postinfection (n
 3/time point/group) and ﬂash frozen in liquid nitrogen. Corneas were
then homogenized in 400 l of PBS with 1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 1 g/ml aprotinin, and 10 g/ml leupeptin (Sigma-
Aldrich, St. Louis, MO). The lysates were centrifuged at 10,000  g for
10 min at 4°C, and the supernatants were used for analysis. ELISAs for
human CXCL-8 and mouse CXCL1, IL-6, CXCL10, IFN-, and IFN-
(all from R&D Systems, Minneapolis, MN) were performed according to
the manufacturer’s instructions. Each sample and standard was analyzed
in duplicate. The plates were read on a microplate reader (Molecular
Devices, Sunnyvale, CA) and analyzed (SoftMax software; Molecular De-
vices).
Flow cytometry. Corneas were dissected from mouse eyes at 4 days
postinfection and cut into small (1- to 2-mm-diameter) fragments for
subsequent digestion with 1 mg/ml collagenase type I and 0.5 mg/ml
DNase (Sigma Chemical Co., St. Louis, MO) (13, 23). Single-cell suspen-
sionswerewashedtwice(300g,5min/wash)inPBSandthenincubated
on ice for 15 min with 2 l anti-mouse Fc block (BD Pharmingen, San
Diego, CA) in a total volume of 100 l PBS-1% BSA. Following incuba-
tion, cells were centrifuged (300  g, 5 min) and resuspended in 5%
normalratserum(JacksonImmunoResearchInc.,WestGrove,PA)foran
additional 15 min on ice. Cells were then labeled with 4 l anti-mouse
ﬂuorescein isothiocyanate (FITC)-conjugated anti-CD45 (clone 30-F11;
BD Pharmingen, San Diego, CA) and incubated in the dark on ice for
30min.Followingincubation,thecellswerewashed3timeswithPBS-1%
BSA (300  g, 5 min/wash) and resuspended in PBS containing 1% para-
formaldehyde. After overnight ﬁxation at 4°C in the dark, cells were pel-
letedandresuspendedinPBS-1%BSAandﬂowcytometrywasperformed
usingaCytomicsFC500(BeckmanCoulter,Brea,CA)forCD45events,
representing the numbers of leukocytes present in infected and control
corneas.
Statistical analysis. ELISAs and ﬂow cytometry experiments were
each performed at least three times. Means of observations were com-
pared by analysis of variance (ANOVA) or Student’s t test, as indicated in
each ﬁgure legend, using statistical analysis software (SAS Institute Inc.,
Cary, NC). Statistical signiﬁcance was set at a P value of 0.05.
Nucleotide sequence accession number. The full genomic sequence
of HAdV-D60 is archived at GenBank (accession no. HQ007053).
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